US Bancorp’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Buy
835
+394
+89% +$188K ﹤0.01% 1572
2025
Q4
$257K Buy
441
+53
+14% +$27.1K ﹤0.01% 1900
2025
Q3
$178K Buy
388
+1
+0.3% +$373 ﹤0.01% 2071
2025
Q2
$117K Sell
387
-127
-25% -$37.8K ﹤0.01% 2349
2025
Q1
$170K Buy
514
+23
+5% +$7.56K ﹤0.01% 2095
2024
Q4
$152K Sell
491
-72
-13% -$20.3K ﹤0.01% 2177
2024
Q3
$119K Sell
563
-229
-29% -$58.6K ﹤0.01% 2307
2024
Q2
$222K Buy
792
+58
+8% +$13.8K ﹤0.01% 1947
2024
Q1
$196K Sell
734
-659
-47% -$155K ﹤0.01% 2022
2023
Q4
$322K Sell
1,393
-854
-38% -$149K ﹤0.01% 1754
2023
Q3
$328K Sell
2,247
-167
-7% -$31.4K ﹤0.01% 1589
2023
Q2
$558K Buy
2,414
+493
+26% +$134K ﹤0.01% 1344
2023
Q1
$465K Buy
1,921
+1,421
+284% +$387K ﹤0.01% 1433
2022
Q4
$145K Buy
500
+142
+40% +$13.9K ﹤0.01% 2030
2022
Q3
$23K Buy
358
+202
+129% +$14K ﹤0.01% 2956
2022
Q2
$11K Sell
156
-194
-55% -$14.3K ﹤0.01% 3339
2022
Q1
$34K Buy
350
+37
+12% +$3.12K ﹤0.01% 2810
2021
Q4
$27K Buy
313
+287
+1,104% +$23.6K ﹤0.01% 2957
2021
Q3
$2K Sell
26
-79
-75% -$6.82K ﹤0.01% 3896
2021
Q2
$10K Sell
105
-8
-7% -$947 ﹤0.01% 3396
2021
Q1
$13K Buy
113
+79
+232% +$9.21K ﹤0.01% 3196
2020
Q4
$4K Buy
34
+26
+325% +$3.18K ﹤0.01% 3454
2020
Q3
$1K Hold
8
﹤0.01% 3604
2020
Q2
$1K Sell
8
-228
-97% -$22.4K ﹤0.01% 3620
2020
Q1
$16K Buy
236
+8
+4% +$667 ﹤0.01% 2851
2019
Q4
$21K Sell
228
-31
-12% -$3.01K ﹤0.01% 2865
2019
Q3
$22K Buy
259
+228
+735% +$21.4K ﹤0.01% 2798
2019
Q2
$3K Hold
31
﹤0.01% 3384
2019
Q1
$4K Hold
31
﹤0.01% 3293
2018
Q4
$3K Sell
31
-67
-68% -$10.4K ﹤0.01% 3322
2018
Q3
$21K Buy
98
+47
+92% +$11.8K ﹤0.01% 2912
2018
Q2
$14K Buy
+51
New +$8.96K ﹤0.01% 3046
2015
Q3
Sell
-16
Closed -$1K 3637
2015
Q2
$1K Buy
+16
New +$1.34K ﹤0.01% 3494

Other funds holding MDGL